International Journal of Organ Transplantation Medicine Isolation and Characterization of Human Mesenchymal Stem Cells Derived from Human Umbilical Cord Wharton's Jelly and Amniotic Membrane

Background: Mesenchymal stem cells (MSCs) have a capacity for self-renewal and multi-potential differentiations. These cells are considered powerful sources for cell therapy in regenerative medicine and tissue engineering. The cells can be isolated from various tissues; however, harvesting from human umbilical cord and amniotic membrane is easy and accessible source.

[1]  Praveen Jha,et al.  Placenta , 2013, Definitions.

[2]  E. Wolvetang,et al.  Differential mesengenic potential and expression of stem cell‐fate modulators in mesenchymal stromal cells from human‐term placenta and bone marrow , 2012, Journal of cellular physiology.

[3]  R. Ramasamy,et al.  Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue. , 2012, World journal of stem cells.

[4]  C. Cetrulo,et al.  Wharton's Jelly stem cells: future clinical applications. , 2011, Placenta.

[5]  E. Wróbel,et al.  Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion , 2011, Cellular & Molecular Biology Letters.

[6]  F. Farina,et al.  New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. , 2010, Stem cells and development.

[7]  F. Farina,et al.  Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers , 2009, Histochemistry and Cell Biology.

[8]  M. Weiss,et al.  Immune Properties of Human Umbilical Cord Wharton's Jelly‐Derived Cells , 2008, Stem cells.

[9]  Yuanlin Liu,et al.  Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. , 2008, Blood.

[10]  Ross Crawford,et al.  Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis. , 2007, Tissue engineering.

[11]  Hermann Eichler,et al.  Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.

[12]  Anthony Atala,et al.  Recent developments in tissue engineering and regenerative medicine , 2006, Current opinion in pediatrics.

[13]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[14]  C. Fuhrer,et al.  Laminin-1 redistributes postsynaptic proteins and requires rapsyn, tyrosine phosphorylation, and Src and Fyn to stably cluster acetylcholine receptors , 2002, The Journal of cell biology.

[15]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[16]  J. Challis,et al.  The characterization of human amnion epithelial and mesenchymal cells: the cellular expression, activity and glucocorticoid regulation of prostaglandin output. , 2000, Placenta.

[17]  P. Conget,et al.  Mesenchymal progenitor cells in human umbilical cord blood , 2000, British journal of haematology.

[18]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[19]  Y. Moodley,et al.  Human fetal membranes: a source of stem cells for tissue regeneration and repair? , 2009, Placenta.

[20]  S. Strom,et al.  Amnion-derived pluripotent/multipotent stem cells , 2006, Stem Cell Reviews.

[21]  O. Ringdén,et al.  Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells , 2004, Bone Marrow Transplantation.

[22]  K. Le Blanc.  Immunomodulatory effects of fetal and adult mesenchymal stem cells. , 2003, Cytotherapy.